Hot Topics: Politics

Blog Posts (127)

May 23, 2017

Dear Mr. President: It’s Time for Your Bioethics Commission

by Craig Klugman, Ph.D.

Last week, seven Democratic members of the U.S. House Representatives sent a letter to the White House asking President Trump to appoint a director to the Office of Science and Technology Policy (OSTP), position that normally serves as the presidential science advisor.…

April 25, 2017

Why I Marched

by Craig Klugman, Ph.D.

This past Saturday, I donned by pink knitted brain hat and joined 40,000 other scientists and allies in Chicago’s Grant Park.…

April 24, 2017

BioethicsTV: Henrietta Lacks and “Mary Kills People”

by Craig Klugman, Ph.D.

This past weekend was a bioethics bonanza when it came to cable television. First, HBO premiered its film version of The Immortal Life of Henrietta Lacks, seven years after the book’s original publication.…

April 5, 2017

Internet Privacy and Health Portals: Why I Won’t Be Contacting My Doctor Online

by Craig Klugman, Ph.D.

Part of the Affordable Care Act was an effort to increase efficiency in sharing and storing health data through electronic health records.…

March 29, 2017

The ACA Survived, Do We Have the Political Will to Make It Better?

by Craig Klugman, Ph.D.

The Republican-backed American Health Care Act was withdrawn before a vote on Friday when it appeared to lack the support needed to pass.…

March 17, 2017

Ethics of the Trump Budget: The Social Contract is Dead

by Craig Klugman, Ph.D.

President Trump released his blueprint for a 2018 federal budget. From an ethical standpoint, the President seems to operates from a Hobbesian standpoint—life is nasty, brutish and short.…

March 7, 2017

The Ethics of the New GOP Health Plan – Violating Justice & Solidarity

by Craig Klugman, Ph.D.

Whatever one may think of the Affordable Care Act (ACA), it began with noble intentions. The ACA was built on a philosophy of providing more people not only with access to health insurance but also with assistance to pay for it.…

March 3, 2017

March for Science

If anything can be gleaned from the early days of the new administration in Washington, it is that a lot of Americans appear eager to march. The sheer numbers of marches chronicled since the election and into the nascent days of the victors’ succession would impress John Philip Sousa. The newest entry is the “March for Science,” an event to be held on April 22nd,... // Read More »
February 21, 2017

Ethics, refugees, and the President’s Executive Order

by Nancy Kass, ScD
There are different political philosophies about the responsibilities of states regarding whether to accept refugees. While there is a political philosophy that might be called Nationalist in perspective that says, essentially, “Not my Problem,” the predominant philosophy globally is different.…

February 17, 2017

Ethics & Society Newsfeed: February 17, 2017

Politics Trump Ethics Monitor: Has The President Kept His Promises? To track Trump’s ethics-related promises, NPR checked debate transcripts, campaign speeches and press conferences Trump’s South Florida estate raises ethics questions Ethics questions and possible conflicts surrounding President Donald Trump’s frequent trips to his sprawling Mar-a-Lago property, especially in regards to the invitation of Japanese Prime … More Ethics & Society Newsfeed: February 17, 2017

View More Blog Entries

Published Articles (21)

American Journal of Bioethics: Volume 17 Issue 5 - May 2017

Ethics, Refugees, and the President's Executive Order Nancy E. Kass

American Journal of Bioethics: Volume 17 Issue 5 - May 2017

Genetic Fingerprints and National Security Beau P. Sperry, Megan Allyse & Richard R. Sharp

American Journal of Bioethics: Volume 15 Issue 6 - Jun 2015

U.S. Complicity and Japan's Wartime Medical Atrocities: Time for a Response Katrien Devolder

American Journal of Bioethics: Volume 15 Issue 2 - Feb 2015

Ritual Male Infant Circumcision and Human Rights Allan J. Jacobs & Kavita Shah Arora

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

Personalities, Politics, and Bioethics

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

Dead Man Walking?Politics, Sr. Helen Prejean, and the Vocation of the Bioethicist

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

The Political Satirist as Public Intellectual: The Case of Jon Stewart

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

William B. Hurlbut: Building a Bridge Over Troubled Stem Cell Waters

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

Toward a ?Magenta? Public Bioethics Discourse?Bart Stupak and Health Care Reform

American Journal of Bioethics: Volume 11 Issue 12 - Dec 2011

Reason Giving: When Public Leaders Ignore Evidence

View More Articles

News (467)

April 27, 2017 9:00 am

California’s $3-billion bet on stem cells faces final test (Nature)

When California voters approved US$3 billion in funding for stem-cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinson’s disease and spinal-cord injuries. Now, the pot of money — one of the biggest state investments in science — is running dry before treatments have emerged, raising questions about whether Californians will pour billions more into stem-cell research.

April 11, 2017 9:00 am

Congress and FDA nominee heap love on ‘adaptive trials’ (Science)

This week, as President Donald Trump’s nominee to head FDA, Gottlieb sat before Republican lawmakers hungry for promises of “shorter time frames” for drug and device approvals, and again expressed his zeal—repeatedly—for adaptive trial designs. If confirmed to be FDA’s head, as expected, Gottlieb suggested he’d promote wider use of the approach.

April 7, 2017 9:00 am

Few U.S. animal inspections are being posted (Science)

The Donald Trump administration appears to have reversed its decision to remove from public sight the results of past government inspections of animal research facilities. But getting hold of new inspection reports is proving to be another matter. An animal welfare researcher has found that only four reports have been posted during the first quarter of 2017.

April 6, 2017 9:00 am

Trump Completes Repeal of Online Privacy Protections From Obama Era (Washington Post)

President Trump on Monday signed a congressional resolution to complete the overturning of internet privacy protections created by the Federal Communications Commission during the Obama administration. The change will allow broadband internet service suppliers, such as cable and telecommunications companies, to track and sell a customer’s online information with greater ease.

April 5, 2017 9:00 am

New EPA documents reveal even deeper proposed cuts to staff and programs (Washington Post)

The Environmental Protection Agency has issued a new, more detailed plan for laying off 25 percent of its employees and scrapping 56 programs including pesticide safety, water runoff control, and environmental cooperation with Mexico and Canada under the North American Free Trade Agreement.

April 3, 2017 9:00 am

Donald Trump believes the solution to the opioid crisis is talk (Vox)

President Donald Trump will soon sign an executive order to tackle what he’s called the “total epidemic” of opioid abuse and addiction. The main objective of the order is to create a commission that’s tasked with publishing a report on what to do about America’s deadliest drug crisis ever.

March 28, 2017 9:00 am

Dying patients want easier access to experimental drugs. Experts say that’s bad medicine (Watertown Daily Times)

DeBartoli walks with difficulty and falls frequently. He’s losing his ability to breathe on his own. Now the 55-year-old from Tracy, Calif., has pinned his hopes on an experimental drug made by Genentech — and a new “right-to-try” law that allows desperate patients to take medications before they’ve been fully vetted by the Food and Drug Administration. The measure’s newest fan is President Donald Trump, who said the FDA’s caution in granting dying patients access to some medications had “always disturbed” him. But for all its populist appeal, the push for right-to-try laws has raised the ire of ethicists, drug safety experts and a former FDA commissioner.

March 8, 2017 9:00 am

Trump plan for 40% cut could cause EPA science office ‘to implode,’ official warns (Science)

The Trump administration wants to cut spending by EPA’s Office of Research and Development (ORD) by more than 40% from roughly $510 million to $290 million, according to sources that have seen preliminary directives from the White House’s Office of Management and Budget (OMB). The cuts target scientific work in fields including climate change, air and water quality, and chemical safety. EPA’s $50 million external grant program for environmental scientists at universities would disappear altogether. Such erasures represent just part of a larger plan to shrink EPA’s budget by 25% to $6.1 billion.

March 3, 2017 9:00 am

A divided White House still offers little guidance on replacing Obamacare (Washington Post)

A meeting Friday afternoon between President Trump and Ohio Gov. John Kasich, his former rival in the GOP primaries, had no set agenda. But Kasich came armed with one anyway: his hope to blunt drastic changes to the nation’s health-care system envisioned by some conservatives in Washington.

February 16, 2017 9:00 am

Speedy drug approvals are risky, but drug companies have another idea that's just terrible (Los Angeles Times)

As with Trump’s proposed elimination of consumer safeguards, environmental-protection measures and financial reforms, the reality is that if his administration proceeds with a wholesale deregulation of the drug industry, the public will be largely undefended against the aggressive and potentially dangerous predations of multibillion-dollar conglomerates.

View More News Items